+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 40Years - 75Years
All Genders
ID05955846

Clinical Trial Evaluating Safety and Vision Outcomes of the Z Virtual Aperture Optic Intraocular Lens After Cataract Surgery

Led by Z Optics, Inc. · Updated on 2026-09-18

60

Participants Needed

8

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the safety and effectiveness of a new intraocular lens IOL called the Z Virtual Aperture Optic IOL for adults aged 40 to 75 who have bilateral cataracts and presbyopia. Cataracts cause cloudiness in the eye lens leading to vision changes, while presbyopia affects near and intermediate vision due to loss of the eyes ability to focus with age. The study seeks to improve vision after cataract surgery and reduce the need for glasses. Participants will undergo cataract surgery with phacoemulsification to remove the cloudy natural lens, followed by implantation of the Z Virtual Aperture Optic IOL in both eyes, one month apart. This IOL is designed to correct distance vision like a monofocal lens but also increase depth of focus to enhance near and intermediate vision. Subjects will be followed for 12 months after surgery to monitor outcomes. During the study, participants will have regular assessments of their visual acuity, including binocular uncorrected visual acuity and defocus curves, along with safety checks such as intraocular pressure and slit lamp examinations. Questionnaires will capture patient experience over 12 months. The main measure of success is binocular photopic uncorrected visual acuity at 6 months. Safety and effectiveness will be closely monitored throughout the follow-up period.

CONDITIONS

Brief Title

Evaluation of Safety and Effectiveness of an IOL With a Virtual Aperture Optic

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here